|
Age in years (mean ± SD)
|
70.5 ± 10.8
|
70.4 ± 10.9
|
0.9
|
|
Age ≥ 65-year-old, n(%)
|
82 (65.5)
|
54 (69.2)
|
0.7
|
|
Men, n (%)
|
56 (45.9)
|
44 (56.4)
|
0.2
|
|
Smoking status, n (%)
|
|
Never
|
6 (4.9)
|
10 (12.8)
|
0.005
|
|
Former
|
57 (46.7)
|
20 (25.6)
|
|
Current
|
56 (45.9)
|
46 (58.9)
|
|
PFT ever done, n (%)
|
70 (57.3)
|
77 (98.7)
|
< 0.001
|
|
Obstructive pattern confirmed on PFT (%)
|
42 (60.0)
|
66 (85.7)
|
< 0.001
|
|
FEV1/FVC (mean ± SD)
|
69.4 ± 11.3
|
65.1 ± 14.6
|
0.07
|
|
Airflow limitation by FEV1 in those with obstructive pattern, n (%)
|
|
GOLD 1 (mild)
|
8 (19.0)
|
7 (10.6)
|
0.02
|
|
GOLD2 (moderate)
|
28 (66.6)
|
30 (45.5)
|
|
GOLD 3 (severe)
|
5 (11.9)
|
24 (36.4)
|
|
GOLD 4 (very severe)
|
1 (2.4)
|
5 (7.5)
|
|
PCV13, n (%)
|
71/87 (81.6)
|
57/59 (96.6)
|
0.009
|
|
PPSV23, n (%)
|
100/118 (84.7)
|
74/78 (94.8)
|
0.03
|
|
Influenza vaccination 2017, n (%)
|
77(63.1)
|
63(80.8)
|
0.008
|
|
Influenza vaccination 2018, n (%)
|
76(62.8)
|
62(80.5)
|
0.008
|
|
Influenza vaccination 2019, n (%)
|
60 (52.2)
|
53(70.7)
|
0.01
|
|
COPD hospitalization in prior 12 months, n (%)
|
3 (2.4)
|
16 (20.5)
|
< 0.001
|
|
Death in 2017–2019, n (%)
|
8 (6.5)
|
5 (6.4)
|
1.0
|
